UNSPSC 51372500: Controlled substance analgesics, synthesized

This classification denotes Controlled substance analgesics composed of multiple constituents, with no dominant constituent.

UNSPSC 51372500 Controlled substance analgesics, synthesized is a Class code encompassing the procurement of synthesized pain-management medications and related drug-management systems by state and local health agencies. State and local governments buy naloxone, drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through this code to support community health initiatives, pharmacy benefit programs, and emergency response capabilities. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. Seminole County, Florida and the Texas Health and Human Services Commission are recent active buyers; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serves multiple states including Oregon through centralized procurement vehicles.

Recent activity spans Florida, Texas, and the Upper Midwest. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, response deadline July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on vendors' direct-contracting experience with self-insured employers and negotiated net pricing models outside traditional pharmacy benefit manager arrangements. MMCAP released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), with proposals due March 26, 2026, and contract effectiveness July 1, 2026. MMCAP evaluates submissions on price competitiveness (75 percent weight), fixed pricing (10 percent), compliance with administrative fee data format and EDI capability (5 percent each), and agreement to a 3 percent administrative fee (5 percent).